microphthalmia, syndromic 9
microphthalmia, syndromic 9
Explore linked clinical trials. Standard reference: MONDO:00110106 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| CHemotherapy And Stool Transplant in PDAC (CHASe-PDAC) | microphthalmia, syndromic 9 | Active, not recruiting | Phase 1 | 2026-10-02 | NCT06393400 | |
| Personalized First-line Chemotherapy Choice in Advanced Pancreatic Adenocarcinoma Using Transcriptomic Signatures | Carcinoma, Ductal, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Ductal, Lobular, and Medullary, adenocarcinoma, carcinoma, endocrine system disorder, epithelial neoplasm, malignant endocrine neoplasm, microphthalmia, syndromic 9, neoplasm, pancreas disorder, pancreatic ductal adenocarcinoma, pancreatic neoplasm | Active, not recruiting | Not applicable | 2026-10-01 | NCT05475366 | |
| Study to Assess Safety, Tolerability and Activity of DSB2455 in Participants With Advanced Malignancies | Fanconi anemia complementation group D1, Fanconi anemia complementation group N, microphthalmia, syndromic 9 | Recruiting | Phase 1 | 2026-09-02 | NCT06458712 | |
| Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan | Digestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Skin and Connective Tissue Diseases, Thoracic Neoplasms, breast disorder, breast neoplasm, bronchial neoplasm, bronchogenic carcinoma, carcinoma, digestive system disorder, digestive system neoplasm, endocrine system disorder, epithelial neoplasm, esophageal disorder, gastric neoplasm, head and neck squamous cell carcinoma, lung disorder, lung neoplasm, malignant endocrine neoplasm, malignant pancreatic neoplasm, microphthalmia, syndromic 9, neoplasm, non-small cell lung carcinoma, pancreas disorder, pancreatic neoplasm, respiratory system disorder, respiratory tract neoplasm, skin disorder, squamous cell carcinoma, stomach disorder, triple-negative breast carcinoma | Recruiting | Phase 1 | 2026-06-23 | NCT05005403 | |
| A Phase II Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy | microphthalmia, syndromic 9 | Active, not recruiting | Phase 2 | 2025-12-05 | NCT07176702 | |
| Surufatinib Combined With Gemcitabine Plus Nab-paclitaxel in Locally Advanced Pancreatic Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, endocrine system disorder, malignant endocrine neoplasm, malignant pancreatic neoplasm, microphthalmia, syndromic 9, neoplasm, pancreas disorder, pancreatic neoplasm | Not yet recruiting | Phase 2 | 2024-04-11 | NCT06361030 |